Lung ischemia-reperfusion injury (LIRI) and primary graft dysfunction are leading causes of
morbidity and mortality among lung transplant recipients. Although extensive research …

Lung transplantation (LTx) is the gold standard treatment for end-stage lung disease;
however, waitlist mortality remains high due to a shortage of suitable donor lungs. Organ …

Despite the widespread use of antibiotics, bacterial pneumonias in donors strongly
predispose to the fatal syndrome of primary graft dysfunction (PGD) following lung …

Rationale: Primary graft dysfunction (PGD) is the leading cause of early morbidity and
mortality after lung transplantation. Prior studies implicated proxy-defined donor smoking as …

Primary graft dysfunction after lung transplantation : Current Opinion in Organ
Transplantation Primary graft dysfunction after lung transplantation : Current Opinion in …

Objective A small but growing proportion of lung transplant recipients survive longer than a
decade post-transplant. The aim of this study was to identify factors associated with survival …

Objective: The objective of this study was to examine early lung transplant outcomes
following EVLP using a large national transplant registry. Summary of Background Data …

Lung transplantation is an established treatment option that can improve quality of life and
prolong survival for select patients diagnosed with end-stage lung disease. Given the gaps …

Solid organ transplantation is a life-saving intervention for patients suffering from end-stage
organ failure. Although improvements in surgical techniques, standards of care, and …

Background The demand for donor lungs continues to outpace the supply, yet nearly 75% of
donor lungs intended for lung transplantation are discarded. Methods We reviewed all …